CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Activity

24 hedge funds and large institutions have $3.22M invested in Cellectar Biosciences in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Holders
24
Holders Change
+4
Holders Change %
+20%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACM
1
AIGH Capital Management
Maryland
$1.59M
2
WVP
2
Worth Venture Partners
New Jersey
$576K
3
CH
3
CVI Holdings
Delaware
$284K
4
Renaissance Technologies
4
Renaissance Technologies
New York
$80K
5
Citadel Advisors
5
Citadel Advisors
Florida
$31.9K

Top Sellers

1
DCM
1
Difesa Capital Management
New York
$0
2
IA
2
IFP Advisors
Florida
$0
3
Bank of New York Mellon
3
Bank of New York Mellon
New York
$20.6K
Name Holding Trade Value Shares
Change 		Shares
Change %
IA
26
IFP Advisors
Florida
– -$1K – –
1
2